Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,229 | 28,957 | 91,529 | 77,383 | 48,310 |
| Marketable Securities | 102,557 | 103,993 | 46,670 | N/A | N/A |
| Receivables | N/A | N/A | 5,010 | N/A | N/A |
| TOTAL | $125,508 | $136,077 | $146,894 | $80,506 | $51,224 |
| Non-Current Assets | |||||
| PPE Net | 3,073 | 3,210 | 3,606 | 3,707 | 4,002 |
| Other Non-Current Assets | 389 | 389 | 389 | 389 | 3,143 |
| TOTAL | $3,462 | $3,599 | $3,995 | $4,096 | $7,145 |
| Total Assets | $128,970 | $139,676 | $150,889 | $84,602 | $58,369 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,405 | 2,381 | 3,409 | 1,143 | 1,590 |
| Accrued Expenses | 5,669 | 4,256 | 3,832 | 3,642 | 3,410 |
| Other current liabilities | 389 | 430 | 436 | 471 | 457 |
| TOTAL | $15,591 | $13,080 | $13,442 | $9,256 | $5,457 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,128 | 6,013 | 5,765 | 4,000 | N/A |
| Other Non-Current Liabilities | 2,200 | 2,210 | 2,218 | 2,225 | 2,219 |
| TOTAL | $3,332 | $3,985 | $5,518 | $2,225 | $2,219 |
| Total Liabilities | $18,923 | $17,065 | $18,960 | $11,481 | $7,676 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,069 | 3,059 | 3,047 | 3,042 | 2,729 |
| Common Shares | 2 | 2 | 2 | 2 | 1 |
| Retained earnings | -202,107 | -187,476 | -175,089 | -161,950 | -148,734 |
| Other shareholders' equity | 74 | 177 | 7 | 20 | 175,503 |
| TOTAL | $110,047 | $122,611 | $131,929 | $73,121 | $50,693 |
| Total Liabilities And Equity | $128,970 | $139,676 | $150,889 | $84,602 | $58,369 |